-

Thomas H. Lee Partners Appoints Healthcare and Employee Benefits Industry Leader Dave Guilmette as Executive Partner

Industry veteran brings over 40 years of global leadership experience to support insurance investment strategy

BOSTON--(BUSINESS WIRE)--THL Partners (“THL”), a premier private equity firm investing in middle-market growth companies, today announced that Dave Guilmette has joined the firm as an Executive Partner in its Financial Technology & Services investment group. Guilmette brings over 40 years of experience in building, leading, and transforming global healthcare and employee benefits businesses.

In his role, Guilmette will support THL’s efforts to identify, source, and grow investment opportunities across the insurance, benefits, and broader financial services ecosystem. He will also work closely with portfolio company management teams to drive operational excellence and long-term value creation.

“We are thrilled to welcome Dave to THL,” said Ganesh Rao, Managing Director and Head of Financial Technology & Services at THL. “Dave’s deep expertise across employee benefits — combined with his experience leading scaled, global organizations — will be invaluable as we continue to invest behind businesses that serve employers, insurers, and consumers. He has a proven ability to drive growth and build high-performing teams, and we look forward to partnering with him across our portfolio.”

Guilmette has served as CEO, President, strategic advisor, and board director for leading global organizations. Throughout his career, he has driven sustainable growth by aligning employee benefits program design and delivery with evolving market needs. He has significant experience analyzing competitive dynamics and customer demand to position businesses for growth and accelerate performance. In addition, he has been actively involved in evaluating and advising on investment opportunities.

“THL has established a strong reputation for combining deep sector expertise with operational partnership,” said Guilmette. “I’m excited to join the firm’s Financial Technology & Services team and to work alongside management teams to identify growth opportunities, enhance capabilities, and deliver meaningful value for customers and investors.”

THL’s Financial Technology & Services team partners with companies across insurance and adjacent financial services, supporting businesses as they work to transform and modernize the insurance industry and create sustainable, long-term value.

Guilmette currently serves on the board of Sword Health Technologies, Inc. and as a board advisor for The Grey Area, a nonprofit organization supporting individuals experiencing acute neurological disorders. He also supports the University of Michigan Marching Band through student scholarship initiatives.

About THL Partners

THL Partners is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions. THL couples deep sector expertise through an Identified Sector Opportunity (“ISO”) process with dedicated internal operating resources from its Strategic Resource Group (“SRG”) to transform and build great companies of lasting value in partnership with management. The Firm’s domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations, and drive long-term sustainable value. Since 1974, THL has managed or deployed $50 billion of equity capital, worked with over 175 partner companies around the world and fueled more than 700 add-on acquisitions representing an aggregate enterprise value of over $260 billion.

Contacts

Edelman Smithfield
Nicole Hakimi
Nicole.Hakimi@edelmansmithfield.com

Thomas H. Lee Partners, L.P.


Release Versions

Contacts

Edelman Smithfield
Nicole Hakimi
Nicole.Hakimi@edelmansmithfield.com

More News From Thomas H. Lee Partners, L.P.

THL Partners Raises $6.35 Billion of Investable Capital for Fund X

BOSTON--(BUSINESS WIRE)--THL Partners, a premier private equity firm investing in middle-market growth companies, today announced the final close of THL Equity Fund X, L.P. (“Fund X”) with $6.35 billion in investable capital. Fund X received strong support from a diverse group of both existing and new investors, including public and corporate pension funds, sovereign wealth funds, financial institutions, and family offices across North America, Latin America, Europe, Asia, Australia, and the Mi...

Celerion Announces Majority Investment from THL Partners

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a global leader in clinical pharmacology and bioanalytical sciences, today announced a majority investment from THL Partners (“THL”), a premier private equity firm investing in middle market growth companies. The investment will support Celerion’s continued growth and innovation, including expanding its clinical and bioanalytical capabilities and advancing its work to help pharmaceutical and biotechnology partners bring new therapies to patients worldwi...

THL Announces Agreement to Acquire Headlands Research from KKR

LAKE WORTH, Fla. & NEW YORK--(BUSINESS WIRE)--THL Partners (“THL”), a premier private equity firm investing in middle market growth companies, today announced the entry into a definitive agreement to acquire Headlands Research (“Headlands” or “the Company”), a leading multinational network of clinical trial sites, from funds managed by leading global investment firm KKR. The strategic partnership between THL and Headlands will fuel Headlands’ continued expansion, enhance its technology and cent...
Back to Newsroom